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ABSTRACT
It has become clear that the products of several of the
earliest identified myelin protein genes perform functions
that extend beyond the myelin sheath. Interestingly, these
myelin proteins, which comprise proteolipid protein, 29,39-
cyclic nucleotide 39-phosphodiesterase and the classic and
golli MBPs (myelin basic proteins), play important roles
during different stages of oligodendroglial development.
These non-myelin-related functions are varied and include
roles in the regulation of process outgrowth, migration,
RNA transport, oligodendrocyte survival and ion channel
modulation. However, despite the wide variety of cellular
functions performed by the different myelin genes, the
route by which they achieve these many functions seems
to converge upon a common mechanism involving Ca
2+
regulation, cytoskeletal rearrangements and signal trans-
duction. In the present review, the newly emerging
functions of these myelin proteins will be described, and
these will then be discussed in the context of their
contribution to oligodendroglial development.
Key words: amyloid b-peptide (Ab), calmodulin (CaM),
central nervous system (CNS), extracellular matrix (ECM),
oligodendrocyte (OL), proteolipid protein (PLP).
INTRODUCTION
The myelin membrane provides an insulating sheath that
facilitates the rapid conduction of electrical impulses along
nerve fibres of the PNS (peripheral nervous system) and the
CNS (central nervous system). Although mostly composed of
lipids, these specialized extensions of the OL (oligodendro-
cyte) and Schwann cell membrane also contain a number of
proteins, the so-called myelin proteins, which play a pivotal
role in providing structure and integrity to the myelin sheath.
In the CNS, the major myelin proteins include myelin PLP
(proteolipid protein) and the related product DM20, MBP
(myelin basic protein), MAG (myelin-associated glycoprotein)
and CNP (29,39-cyclic nucleotide 39-phosphodiesterase). PLP
and MBP are distributed within the myelin sheath and appear
to be integral to the process of compaction that generates
the closely apposed multilayered structure of mature myelin.
MAG, on the other hand, is located in the periaxonal regions
and may serve to facilitate cell–cell interactions between
myelin and axonal membranes during the establishment of
myelination. CNP is understood less well. Although it exhibits
enzymatic activity in vitro, substrates for this action have not
been identified within the myelin sheath and it has been
proposed that this molecule may instead perform a structural
role in the myelin membrane (Newman et al., 1995).
The products of myelin genes also appear to perform
functions that extend beyond structural components of the
myelin sheath. For example, as well as producing the well-
known MBP and PLP products, both genes also encode a
second class of protein respectively, called the golli MBP
(Campagnoni et al., 1993; Pribyl et al., 1993) and, in the
mouse, sr-PLP (soma-restricted PLP) proteins (Bongarzone et
al., 1999) that result in alternatively spliced products with
apparently different functions from the classical forms.
Importantly, none of these proteins appear to be components
of the myelin sheath, nor is their expression unique to
myelin-forming cells, suggesting an involvement in cellular
functions that are unrelated to myelination. Consistent with
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specific roles for both ‘classic’ and non-classic-type myelin
gene products that are unrelated to the generation of myelin.
These include roles in the regulation of neurotransmitter
receptors, Ca
2+ channels, protein synthesis and cytoskeleton
dynamics. Many of these newly described functions involve
interactions with intracellular signalling pathways, placing
these molecules in a prime position to influence the
developmental programme of OLs. One interesting and likely
possibility is that these proteins may play a role in controlling
processes such as proliferation, migration and process
extension in OPCs (OL precursor cells). In the present review,
the newly emerging functions of four of these CNS myelin
proteins: classic PLP, CNP, classic MBP and golli MBP, will be
described and these findings will then be discussed with
respect to the developmental processes that accompany the
transition of OPCs into mature myelinating OLs.
PLP
The PLP gene produces two main isoforms, DM20 and PLP.
DM20 protein expression in the CNS is highest during
embryonic development, whereas PLP protein expression
increases in relation to DM20 during postnatal development
(LeVine et al., 1990). PLP protein differs from DM20 by the
inclusion of 35 amino acids within the cytoplasmic domain of
the protein. Two groups have examined the ability of DM20
to substitute the functions of the PLP isoform. Using a
transgenic mouse in which the entire PLP gene was replaced
by an altered gene encoding DM20, Stecca et al. (2000) found
significant alterations in the structure of compacted myelin
that was associated with a pronounced behavioural pheno-
type in aging mice. However, a second so-called DM20only
mouse generated by replacing PLP exon III (responsible for
generation of the PLP isoform) with a truncated exon III,
lacking a critical sequence, formed essentially healthy myelin
and did not exhibit a pathological phenotype, even after 48
months (Sporkel et al., 2002). Thus whether or not the DM20
and PLP isoforms perform different functions during the
formation of compacted myelin remains unclear. Nonetheless,
the identification of DM20 in non-myelinating cells suggests
an alternative function for the protein in these cells
(Campagnoni et al., 1992; Pribyl et al., 1996a, 1996b; Feng
et al., 2003; Skoff et al., 2004a). Apart from its expression in
mature OLs, the gene encoding PLP is also expressed in OPCs
(Gudz et al., 2006), neurons (Bongarzone et al., 1999; Jacobs
et al., 2003, 2004; Miller et al., 2003, 2009), embryonic neural
precursors (Spassky et al., 1998; Delaunay et al., 2009) and
non-neural cells (Campagnoni et al., 1992; Skoff et al.,
2004a). The presence of PLP proteins in non-myelinating cells
suggests an involvement in other functions unrelated to
myelination. In line with this idea, PLP has been linked to the
regulation of several cellular processes including ion
exchange, cell migration and programmed cell death. These
processes, all of which make important contributions to OPC
development, will be discussed in the following sections.
Ion exchange
The earliest evidence linking PLP to transmembrane ion
exchange came from studies using artificial plasma mem-
branes. First, insertion of white-matter-derived PLP into lipid
bilayers conferred these synthetic membranes with ionic
currents. These conductances were voltage-dependent (Ting-
Beall et al., 1979), and could be resolved at the level of single
channels (Helynck et al., 1983), indicating an involvement of
these proteins in the formation of ion channels in the plasma
membrane. Secondly, studies using proteoliposomes contain-
ing PLP revealed that Ca
2+ movements across these
membranes were regulated by the interaction between PLP
proteins and nucleotides such as MgATP (Diaz et al., 1990),
providing further evidence of an involvement of the proteins
in the exchange of ions across plasma membranes. Despite
improvements in the techniques available for the examina-
tion of ion channel function in situ, few studies have
attempted to examine the interactions of PLP with ion
channels in intact cells (but see Gudz et al., 2006), and it is
therefore unclear whether the functions that arise in
synthetic preparations are representative of an endogenous
role for PLP.
Transmembrane signalling, maturation and cell
migration
As a membrane protein, PLP is well placed to participate in
the transduction of signals between the ECM (extracellular
matrix) and the interior of the cell. One potential route by
which this may occur involves signalling through integrins,
cell-surface proteins that function as receptors to ECM
molecules. Through their communication with intracellular
signalling pathways, integrins are well placed to stimulate a
wide range of cellular actions, including migration, prolifera-
tion, differentiation and survival (Harburger and Calderwood,
2009). Importantly these effects are known to extend to cells
in the OL family where integrins have been shown to
influence survival (Frost et al., 1999), migration (Milner et al.,
1996) and proliferation (Blaschuk et al., 2000). Given the
multitude of cellular behaviours affected by ECM–integrin
signalling, the ability to influence these interactions would
confer PLP with a considerable degree of control over these
key developmental processes. This possibility was advanced by
the discovery that PLP forms a complex in OLs containing
avb5 integrin and calreticulin, a Ca
2+-binding protein (Gudz
et al., 2002). The consequences of this complex for integrin
function were revealed by studies showing enhanced levels of
binding of OLs to the ECM protein fibronectin. Interestingly
these actions were stimulated by the activation of mAchRs
(muscarinic acetylcholine receptors), suggesting a role for
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OLs. How might these interactions between neurotransmitter
signals and the PLP–avb5 complex regulate OL function?
avb5 expression appears in differentiated OLs (Milner and
Ffrench-Constant, 1994), and the activity of this integrin is
associated with several features of maturation, including
process extension and MBP protein expression (Blaschuk et
al., 2000). Thus the sensitivity of PLP–avb5 activity to
neurotransmitters such as acetylcholine may provide a means
by which neuronal activity may regulate OL maturation and
subsequent myelination.
Further work by Gudz et al. (2006) identified a similar
complex in OPCs, this time involving an interaction between
PLP and avb3 integrin which is involved in regulating the
migration of these cells. Gudz et al. (2006) found that the
ionotropic glutamate receptor agonist AMPA (a-amino-3-
hydroxy-5-methylisoxazole-4-propionic acid) stimulated the
formation of this complex, and that this action produced a
significant enhancement in OPC migration. Importantly, this
effect was absent from OPCs lacking PLP, showing that
AMPA-receptor-dependent migration required the participa-
tion of PLP. Additionally, experiments measuring the ability of
OPCs to bind to fibronectin indicated that binding to this
ECM protein was reduced when cells were stimulated with
AMPA (Gudz et al., 2006). Taken together, these results
suggest that AMPA-dependent increases in migration stem in
part from a reduction in ECM–integrin binding that in turn
enhances the motility of these cells. These results also
strengthen the hypothesis that PLP, through its actions as
part of an integrin-containing complex, provides a means by
which neurotransmitters may influence oligodendroglial
function. Given the recent discovery of glutamatergic
synaptic connections between unmyelinated callosal axons
and white matter OPCs (Kukley et al., 2007; Ziskin et al.,
2007), it will be intriguing to find out whether these AMPA
receptor–PLP interactions also influence OPC migration in the
more intact cellular environment provided by tissue slices.
OL survival
Studies of mutations in the PLP gene reveal an interesting
dichotomy between effects on OL survival and myelination.
While many PLP gene mutations result in the impairment of
myelin sheath formation, these mutations are also associated
with a substantial decrease in the survival of OLs (Knapp et
al., 1986; Boison and Stoffel, 1989; Gow et al., 1998), which
has been associated with an accumulation of PLP product in
the ER (endoplasmic reticulum) of OLs, leading to apoptosis
(Gow et al., 1998). Interestingly, the apparent effects of PLP
on OL survival can occur well in advance of the generation of
myelin proteins (Vermeesch et al., 1990). This functional
dissociation is highlighted by the rumpshaker mouse, a PLP
mutation involving a single amino acid substitution, which,
on certain genetic backgrounds, produces significant defi-
ciencies in myelination (Al-Saktawi et al., 2003), but
generates healthy OLs that exhibit a normal level of survival
(Schneider et al., 1992). Therefore, in some instances,
mutations in the gene arise that spare functions related to
survival, while impairing those that are important for
myelination. One interpretation of the results obtained from
PLP mutants is that these proteins perform a role in OL
maturation that precedes the onset of myelin formation and
which is critical to the survival of these cells. However, this
interpretation is complicated by the fact that some of the
effects on OL survival arising from gene mutations stem from
the accumulation of misfolded PLP product in the ER
(Gow et al., 1998; Dhaunchak and Nave, 2007); thus multiple
factors may contribute to reduced OL survival in mice
harbouring mutations in the PLP gene.
Further evidence connecting PLP to OL viability has
emerged from cell culture studies showing opposing effects
on survival when PLP protein expression is either enhanced,
leading to a reduction in survival (Bongarzone et al., 2001), or
reduced, leading to an increase in survival (Yang and Skoff,
1997). In the latter study, antisense molecules targeted to the
initiation codon of PLP were used to decrease the level of PLP
expression. In comparison with untreated cultures, cells
subjected to antisense oligonucleotides showed a 90%
reduction in PLP immunofluorescence, and this reduced level
of PLP protein was associated with visible improvements in
the number of healthy surviving OLs. The effects of PLP on
survival were not restricted to cells in the OL family, or indeed
neural cells. A study by Skoff et al. (2004a) shows that PLP is
expressed in a number of developing non-neural cell types,
and that the levels of PLP in these cells correlates with the
degree of apoptosis. Taken together with the abundance of
data highlighting the close relationship between OL survival
and PLP mis-expression, these results from non-neural cells
indicate that PLP plays a role in regulating apoptosis.
An indication of how PLP may influence cell death in OLs
came from experiments in which neurons were co-cultured
with a cell line expressing PLP. Levels of neuronal apoptosis
were correlated with the number of PLP-expressing cells and,
interestingly, this effect was associated with an acidification
of the medium that was dependent on PLP expression. Since
apoptosis is facilitated under low pH conditions, and
expression of PLP appeared to acidify the medium, it seems
possible that this influence on pH may contribute to the
enhanced level of cell death associated with PLP expression.
These findings were extended by experiments on CNS tissue
isolated from a transgenic line overexpressing PLP in OLs
(Skoff et al., 2004b). In that study, a proton flux assay
revealed an enhanced release of protons from the PLP-
overexpressing tissue. These results raise the possibility that
decreased levels of survival in PLP-mutant OLs may be related
to increased acidification of the surrounding extracellular
space due to increased proton release. Further studies of PLP-
overexpressing tissue have revealed several indications of
mitochondrial dysfunction, including depolarization of the
mitochondrial membrane potential, increased levels of
cytochrome c oxidase and reductions in ATP levels
(Hu ¨ttemann et al., 2009). Overall these results point towards
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27a role for PLP in regulating OL mitochondrial function, which
may in turn be responsible for the disruption in pH
homoeostasis and cell survival associated with increased
levels of PLP expression.
CNP
Constituting 4% of the protein content of the CNS myelin
and expressed earlier than any other myelin protein, CNP
remains something of an enigma: in vitro this molecule
possesses enzymatic activity catalysing the cleavage of 29,39-
cyclic nucleotides to 29-nucleotides; however, years of
research have failed to detect a substrate for this reaction
within the myelin sheath. To date the function of CNP within
the sheath remains unclear, although it has been posited that
this enzymatic activity is now redundant and merely
represents an evolutionary hangover in a molecule that has
evolved to perform new roles (Gravel et al., 2009). Despite the
uncertainty regarding the contribution of CNP catalytic
activity to myelination, there has been significant progress in
identifying functions for CNP beyond the myelin sheath,
including roles in OL process outgrowth and RNA transport.
Here, the focus will be on these CNP functions.
Morphological restructuring and process
outgrowth
Analysis of CNP-null mice reveals that myelin forms normally
in these animals (Lappe-Siefke et al., 2003). However, as these
mice mature they begin to exhibit extensive neurodegenera-
tion with a pronounced decline in axon integrity. These
results point to a distinction between the function of myelin
in supporting high-velocity action potential conduction and
its role in providing trophic support to the axon. A later study
of CNP-KO (knockout) mice revealed deficits in the formation
of the paranodal loop, extensive cytoplasm-filled extensions
of the OL membrane that enwrap the axon on either side of
the node (Rasband et al., 2005). Importantly, these deficits
preceded the onset of axon degeneration, suggesting a
causative role for paranodal loop dysfunction in the decline
in axonal integrity observed in these animals. This idea is
supported by the fact that paranodal loops play an important
role in the organization of nodal components, including
voltage-gated Na
+ channels (Rios et al., 2003), which are
essential to axonal function. These deficits in loop formation
point to a role for CNP in OL process outgrowth, a notion that
is supported by the dramatic increase in membrane expansion
exhibited by OLs in transgenic mice overexpressing CNP (Yin
et al., 1997). The mechanism by which CNP influences process
outgrowth was investigated first in cell lines transfected with
CNP cDNA. Using this approach De Angelis and Braun (1994)
demonstrated that expression of rat CNP in non-neural cell
lines produced dramatic changes in the morphology of these
cells. Exogenous CNP was found to be present at the plasma
membrane, and at particularly high concentrations within
processes and filopodia-like extensions. CNP was found to
stimulate the extension of these filopodia, and these actions
were dependent on prenylation, a reaction involving the
addition of hydrophobic groups, which facilitates membrane
associations. Clearly these actions on process outgrowth
suggest putative interactions with the actin cytoskeleton, an
idea that was confirmed in a second study by De Angelis and
Braun (1996) that showed that CNP is retained within
detergent-insoluble cell fractions (indicating association with
the cytoskeleton) and is co-immunoprecipitated with actin.
Taken collectively, the localization of CNP to the plasma
membrane, the requirement for prenylation in its actions on
process outgrowth and its associations with cytoskeletal
elements suggest that the influence of CNP on process
outgrowth involves the co-ordination of cytoskeletal
dynamics with the plasma membrane.
CNP can also interact with the microtubule cytoskeleton,
since it exhibits binding to soluble tubulin and can stimulate
the polymerization of microtubules (Bifulco et al., 2002; Lee
et al., 2005). These interactions appear to be important for
CNP actions on process outgrowth. Expression of CNP in COS-
7 cells leads to progressive changes in morphology, with cells
passing through two clear stages. Early transformed cells
adopted a flattened ‘spreading’ morphology with many short
membrane protrusions, while late-transformed cells displayed
an OL-like appearance with much elongated highly branched
processes and a smaller cell body. Importantly, these changes
in morphology were reflected by a biphasic pattern of
microtubule dynamics. Early stage cells, which had begun the
process of morphological remodelling, displayed a decrease in
the levels of stable microtubules, whereas late-stage
transformed cells that had acquired elongated OL-like
processes displayed increases in the amount of stable tubulin
filaments. Cell shape and rigidity are provided by cortical
actin, and these F-actin cytoskeletal structures must be
reorganized to permit microtubule-driven protrusions to
extend the membrane. Given the previous associations
identified between CNP and actin (De Angelis and Braun,
1994, 1996) it was likely that CNP-dependent changes in cell
morphology would also involve dynamic changes in the
F-actin cytoskeleton. In line with these expectations,
phalloidin staining revealed reductions in F-actin in CNP-
expressing cells during the early and late stages of
transformation (Lee et al., 2005). Thus CNP-dependent
changes in morphology were associated with co-ordinated
changes in the microtubule and actin cytoskeleton.
To probe the requirement for CNP–actin associations in
process outgrowth and to verify the relevance of these
interactions in oligodendroglial cells, Lee et al. (2005)
transfected OLN-93 cell lines with CNP constructs containing
amino acid deletions. These constructs harboured deletions of
two key C-terminal residues (Lys
379 and Gly
380) previously
identified to be required for the action of CNP on
microtubule polymerization. These experiments revealed that
OLN-93 cells transfected with control CNP exhibited an
increase in the number of processes bearing secondary
branches and in the total number of processes, while the
D Fulton and others
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unaltered. To link these effects in cell lines to native OL
function, Lee et al. (2005) prepared primary cultures of OLs
from CNP-null mice. As discussed above, these CNP-null
animals exhibit deficiencies in the formation of the paranodal
loop (Rasband et al., 2005), which may be related to the
influence of CNP on process outgrowth. In agreement with
this hypothesis, OLs cultured from these animals exhibited
significantly fewer process branches compared with cells
cultured from wild-type animals. Overall these studies in cell
lines, primary cultures and tissues reveal important functions
for CNP in the regulation of OL process outgrowth, which are
likely to depend, at least in part, on the role of CNP as a
regulator of cytoskeleton dynamics. Although these findings
provide important insights into the function of CNP within
OLs, a number of questions still remain. In particular, while
CNP clearly influences morphological remodelling in mature
OLs, it is not clear whether it also exerts a similar influence on
precursor and immature OLs. This seems possible since CNP is
expressed by OPCs (Scherer et al., 1994; Ye et al., 2003;
Gobert et al., 2009), although to date no studies have
examined the influence of this myelin protein on OPC
function.
Roles of CNP2 in cell morphology and
mitochondrial function
The CNP gene produces two isoforms, CNP1 and CNP2, both
of which show robust expression in myelinating glial cells.
Oligodendroglial expression of these isoforms peaks at the
onset of myelination and is then sustained in the adult brain
(Scherer et al., 1994). Previous work by Lee et al. (2006)
revealed that the CNP2 isoform shows both cytoplasmic and
mitochondrial localization. HeLa cells transfected with CNP2
constructs exhibited either predominant cytoplasmic or
mitochondrial CNP2 localization. Interestingly, cells showing
cytoplasmic CNP2 expression exhibited morphological remod-
elling similar to that previously observed in OL cell lines
expressing CNP1 (Lee et al., 2005). However, cell morphology
was not altered when CNP2 expression was restricted to
mitochondria. Thus the function of CNP2 appears to differ
depending on which cytoplasmic compartment it resides in.
Currently there are no results available to explain the role of
CNP2 within mitochondria. CNP2 is also expressed at low
levels in many non-neural tissues (Scherer et al., 1994), where
it appears to be preferentially localized to mitochondria (Lee
et al., 2006). Together, the localization of CNP2 to non-neural
and OL mitochondria, and the cell-compartment-specific
dissociation between CNP2 functions during morphological
restructuring, hint at a more general function beyond the
generation of myelin.
RNA binding and translation inhibition
Several lines of evidence link CNP function to RNA
metabolism. The catalytic domain of mammalian CNP
contains two tetra-residue motifs, H-X-(T/S)-X, which place
it within a superfamily of 2H phosphodiesterases (Kozlov et
al., 2003), several members of which are associated with RNA
editing. Importantly, these structural similarities appear to be
reflected in shared functions since CNP is able to correct the
impaired growth exhibited by yeast cells expressing mutated
versions of two of these H-X-(T/S)-X residue-bearing enzymes
(Schwer et al., 2008). In this study, the growth of yeast cells
expressing mutated copies of tRNA ligase enzymes was
rescued by expression of the rat CNP molecule. Importantly,
CNP constructs harbouring mutations in the H-X-(T/S)-X
motifs did not rescue yeast cell growth. This finding is
significant since the same mutations render the construct
catalytically dead, indicating that this activity is critical to the
ability of rat CNP molecules to contribute to tRNA editing.
Overall this study indicates that rat CNP is able to replace the
function of tRNA ligase enzymes in yeast cells, and is
suggestive of a role for CNP in RNA metabolism in animal
cells. This possibility has received support from a recent study
demonstrating that CNP molecules bind to RNA in vitro, and
that this RNA-binding activity is also present in oligoden-
droglial cells lines (Gravel et al., 2009). RNA-binding activity
was not compromised in a deletion mutant lacking the N-
terminal region, showing that this binding was dependent on
structures located within the catalytic portion of the
molecule. Furthermore, the same catalytically dead mutant
employed by Schwer et al. (2008) was still able to bind RNA.
Thus although RNA binding (Gravel et al., 2009) and potential
editing functions (Schwer et al., 2008) share a requirement
for the catalytic domain, they can be distinguished by the
requirement for CNP catalytic activity, suggesting that these
functions arise from distinct regions within this catalytic
domain.
This RNA-binding facility could have consequences for
protein synthesis. Indeed, translation, as revealed by the
activity of a luciferase reporter and through measurements of
radiolabelled methionine, was significantly reduced by CNP
(Gravel et al., 2009). Two additional lines of evidence suggest
that the inhibitory influence of CNP on protein synthesis is
likely to depend on its ability to interact with RNA. First, as
was the case for the CNP–RNA-binding interactions, protein
synthesis was also disrupted when the catalytically inactive
mutant was included in the translation assay, and secondly,
the closely related CNP homologue RICH (regeneration-
induced CNP homologue), which does not exhibit RNA-
binding activity, was not found to influence protein synthesis
(Gravel et al., 2009). This inhibitory influence on protein
synthesis could have implications for lineage progression as
very recent work has identified the CNP gene as a negative
regulator of OPC maturation (Gobert et al., 2009). In this
study, RNAi (RNA interference) was used to selectively knock
down CNP expression in the oli-neu OPC cell line. Inhibition
of CNP translation increased the expression of PLP and MBP
transcripts, and MBP protein, indicating increased maturation
in this OPC-like cell line. One possibility therefore is that
during OPC development CNP negatively regulates the
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29translation of mRNAs that are required for OL differentiation
such as PLP and MBP.
CNP may also be involved in mediating interactions
between cytoskeletal elements and the translational
machinery since it was found to facilitate associations
between RNA and tubulin (Gravel et al., 2009). These results
suggest an overlap between CNP–RNA binding and the
cytoskeleton interactions described above (Lee et al., 2005),
leading to the suggestion that CNP might have a role in the
transport of RNA molecules along microtubules (Gravel et al.,
2009). This idea has particular relevance to OLs and neurons
since microtubules are known to play an important role in the
binding and localization of RNA in these cells (Jansen, 1999).
Future work is needed to validate this RNA transport
hypothesis and to identify specific RNA molecules that can
be bound by CNP and whose transport and translation may
then be regulated.
THE MBP FAMILY
The MBP family comprises a variety of developmentally
regulated members arising from different transcription start
sites, differential splicing and post-translational modifica-
tions. The MBP gene is very large (.100 kb) and contains
three transcription start sites, generating mRNAs that encode
two families of proteins: classic MBPs and golli MBPs
(Campagnoni et al., 1993; Pribyl et al., 1993). The classic
MBPs are the products of transcription start sites 2 and 3 and
are well known as major protein constituents of the myelin
membrane. As such they are among the most abundant
proteins in the CNS. They are also expressed almost
exclusively in OLs. The classic isoforms of MBP include the
14- and 18.5-kDa isoforms, which predominate in adult
human myelin and facilitate compaction of the mature
myelin sheath, while the exon II-containing 17- and 21.5-kDa
MBPs (MBPexII) are distributed diffusely through the
cytoplasm and often accumulate in the nucleus of OLs
(Allinquant et al., 1991; Hardy et al., 1996; Pedraza, 1997). In
addition to membrane association, the classic MBP isoforms
are able to interact with a multitude of proteins, including
Ca
2+-CaM (calmodulin), actin, tubulin and SH3 domain (Src
homology 3 domain)-containing proteins, and thus may be
signalling linkers during myelin development and remodelling
(Harauz and Libich, 2009).
The golli proteins comprise the second family of proteins
encoded by the MBP gene. These proteins are generated from
the first transcription start site of the gene and are expressed
more ubiquitously within the brain and other organs. In the
mouse, three golli MBP isoforms have been identified: BG21,
J37 and TP8 (Campagnoni et al., 1993). Both BG21 and J37
have segments in common with the classic 18.5 kDa isoform
of MBP, but TP8 differs from this structure due to a
frameshift mutation. They are expressed throughout the
immune system in many cell types, including thymocytes and
T-cells, and in the entire haemopoietic system, as well as in
the nervous system (Feng et al., 2000; Marty et al., 2002;
Feng, 2007).
All proteins in the classic/golli MBP family have intrins-
ically disordered structures (Harauz et al., 2004), creating a
large effective surface to facilitate multiple protein associa-
tions, and are post-translationally modified to various
degrees by methylation, phosphorylation and deimination,
raising the possibility that MBPs might play roles as
scaffolding proteins in intracellular signalling complexes.
Golli MBPs
The primary biological function of the classic MBPs appears
to be that of a myelin structural component (Campagnoni
and Skoff, 2001). Like the classic forms in the CNS, expression
of golli proteins is generally developmentally regulated
(Campagnoni et al., 1993; Landry et al., 1996). It tends to
be high during embryonic development and declines with age
(Landry et al., 1996, 1998). This developmental regulation
does not appear to occur in the PNS, thymus or some brain
regions, such as the olfactory system (Landry et al., 1997). In
the nervous system, golli proteins are expressed in OLs and in
specific subsets of neurons, although golli protein expression
has also been reported in activated microglia, macrophages
and adult OL progenitors around MS (multiple sclerosis)
lesions (Filipovic et al., 2002).
Golli proteins are localized in process extensions
of neural cells
Golli proteins are localized within the cytoplasm and process
extensions of neural cells, and they are often first evident in
these cells when they begin to migrate and extend processes
(Pribyl et al., 1996c; Landry et al., 1997, 1998; Jacobs et al.,
2009). Golli proteins were found in OLs within cell bodies and
processes, including those processes that were contacting and
surrounding axonal fibres (Pribyl et al., 1996c). Within the
lateral funiculus, OLs immunopositive for golli protein can be
seen along fibre tracts. In these cells, golli protein is
distributed throughout the OL cell body, nucleus and the
processes connecting these cells to the myelin sheath as they
envelope axonal segments. Interestingly, immunohistochem-
istry of the embryonic spinal cord with golli antibody also
reveals OLs at the earliest stages of myelin sheath production,
at which point the protein is found to localize to the cell
processes and terminal sheet-like structures (Pribyl et al.,
1996c).
In vitro transfection studies have shown that overexpres-
sion of golli proteins, or indeed the golli domain alone, in OL
cell lines can induce these cells to elaborate extensive
processes and membrane sheets, adopting a morphology
similar to mature OLs in culture (Reyes and Campagnoni,
2002; Paez et al., 2007). Similarly, transfection of golli into
neuronal cell lines results in significant neurite extension, and
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induced by NGF (nerve growth factor; Reyes and
Campagnoni, 2002). These results complement the known
expression of these products in vivo in a number of neuronal
populations and in OL precursors during process extension
and migration. Filipovic et al. (2002) have shown that golli
immunoreactivity is high in adult OL progenitors surrounding
MS plaques prior to remyelination attempts. All these results
combine to suggest a role for golli proteins in process
extension and myelin elaboration.
A role for golli in the nucleus
The golli proteins are also localized in the nucleus of many
cells, and this localization is developmentally sensitive in a
number of neuronal populations. For example, in cerebellar
granule cells in the external granule cell layer, golli is
localized in cell processes, but after their migration into the
inner granule cell layer there is a shift in golli localization to
the nucleus (Landry et al., 1996). It was found that the site
responsible for this translocation is located within the MBP
domain of the golli proteins (Reyes and Campagnoni, 2002).
In other developing systems, this schedule is reversed such
that golli protein expression is first seen within the nucleus or
cell body and is later found only in the fibres. This later
pattern of expression has been observed in neurons within
the neostriatum (Landry et al., 1996) and cortical subplate
(Landry et al., 1998). This behaviour is interesting because
many cell signalling molecules shuttle between the nucleus
and the cytoplasm.
A molecular partner for golli proteins, called GIP (golli-
interacting protein), has been isolated by a yeast two-hybrid
approach, which suggests that, in the nucleus, golli may be
part of a transcriptional regulatory complex (Fernandes et al.,
2004). GIP is a nuclear protein present in all cells in which
golli has been found. It can bind to golli, and it can also bind
to NLI (nuclear LIM interactor), which is known to be
associated with LIM-containing nuclear complexes that are
involved in regulating the transcription of some genes (Jurata
et al., 1996). Thus, in the nucleus, golli is likely to be involved
in the modulation of genes regulated by LIM family members.
Golli as a modulator of VOCCs (voltage-operated
Ca
2+ channels)
Early studies indicated that overexpression of golli proteins in
cells transfected with golli–GFP (green fluorescent protein)
induced immature OL cell lines (e.g. N19) to extend sheets
and processes (Reyes and Campagnoni, 2002). Several studies
in the literature indicate that Ca
2+ is important in OL and OPC
process extension (Pende et al., 1997; Stariha et al., 1997; Yoo
et al., 1999). Since increased levels of both golli and
intracellular Ca
2+ lead to process outgrowth in OPCs, it
seems likely that golli influences Ca
2+ levels, leading to
process extension. Pharmacological experiments demonstrate
that VOCCs were involved in this golli-induced process
extension. In the presence of VOCC antagonists, there was
strong inhibition of process extension and membrane sheet
formation induced by golli, indicating that this remodelling
was mediated by VOCCs (Paez et al., 2007). High-resolution
spatiotemporal analysis revealed that Ca
2+ influx signals were
initiated with different latencies at discrete cellular regions
and were propagated along the N19 cell body and processes.
High correlations between the patterns of local Ca
2+
amplitudes and the patterns of golli protein distribution
were consistently found. Cell regions with golli accumulations
tended to co-localize with high levels of local Ca
2+ signals, i.e.
‘hot spots’. These studies indicated that golli-induced process
extension is associated with increases in Ca
2+ influx and
accumulations of golli near these regions in OPC processes
(Paez et al., 2007). Additionally, a domain analysis of the golli
protein using a deletion approach identified a myristoylation
site at the C-terminus, which appears to be essential for these
golli actions, suggesting that binding of golli to the plasma
membrane is important for modulating Ca
2+ homoeostasis
(Paez et al., 2007).
These studies in cell lines were later confirmed using primary
cultures of OPCs and acute brain slice preparations from golli-
KO (Jacobs et al., 2005) and JOE (J37-golli-overexpressing)
mice (P.M. Paez, D.J. Fulton, V. Spreur, V. Handley, C.W.
Campagnoni and A.T. Campagnoni, unpublished work). Resting
Ca
2+ levelsdid notdifferbetweenKOandcontrolOPCs,butthe
magnitudes of the Ca
2+ response to several stimuli were
significantly lower in KO cells. In contrast and consistent with
the KO results, enhanced Ca
2+ influx was found to be induced
by depolarization of golli-overexpressing cells. This was the
predicted result, and was opposite to the effects observed in
golli-KO OPCs. In golli-overexpressing cells, increases in Ca
2+
uptake were abolished in zero Ca
2+ and were blocked by Cd
2+,
verapamil and nifedipine, confirming that this rise in [Ca
2+]i
(intracellular [Ca
2+]) results from Ca
2+ influx through VOCCs.
Additionally, differences in the amplitude of Ca
2+ uptake
between genotypes were enhanced by Bay K 8644, an L-type
Ca
2+ channel agonist, which enhances channel function by
prolonging single channel open times.
Golli promotes oligodendroglial cell migration
Migration of OL progenitor cells from proliferative zones to
their final location in the brain is an essential step in nervous
system development. As noted above, golli proteins can
modulate voltage-operated Ca
2+ uptake in OPCs during
process extension and retraction (Paez et al., 2007). Given
the importance of process extension/retraction to movement,
Paez et al. (2009a) examined the consequences of golli
expression on OPC migration in vivo and in vitro using time-
lapse imaging of isolated OPCs and in acute brain slice
preparationsfromgolli-KOand golli-overexpressing mice. They
found that golli stimulated migration, and this enhanced
motility was associated with an increase in the activity of
VOCCs. Activation of VOCCs by elevated external [K
+] resulted
in a significant increase in the migration speed of golli-
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31overexpressing OPCs compared with control cells, and golli-
mediated modulation of OPC migration disappeared in the
presence of VOCC antagonists. During migration, OPCs
generated Ca
2+ oscillations that were dependent on voltage-
gated Ca
2+ influx, and both the amplitude and frequency of
these Ca
2+ transients correlated positively with the rate of cell
movement under a variety of pharmacological treatments. The
Ca
2+ transient amplitude and the rate of cell movement were
significantly lower in golli-KO cells and significantly higher in
golli-overexpressing cells, suggesting that the presence of golli
promotes OPC migration by increasing the size of voltage-
mediated Ca
2+ oscillations (Paez et al., 2009a). Thus golli
modulation of VOCCs accelerates cell migration by promoting
Ca
2+-dependent soma translocation and leading to process
formation. This mechanism points to a key role for golli
proteins in regulating the rate of OPC migration through
spontaneous Ca
2+ oscillations and for the first time provides
evidence that functional voltage-gated Ca
2+ channels are
necessary for the migration of OPCs.
Golli enhances store-operated Ca
2+ uptake in
OPCs
The role of golli MBPs in regulating OPC development was
examined in a recent study by Paez et al. (2009b). In OPCs
lacking or overexpressing golli, differentiation induced by
growth factor withdrawal was impaired. Proliferation analysis
in the presence of PDGF (platelet-derived growth factor)
revealed that golli enhanced the mitogen-stimulated prolif-
eration of OPCs through the activation of SOCCs (store-
operated Ca
2+ channels). The PDGF treatment induced a
biphasic increase in OPC intracellular Ca
2+, and golli
specifically increased Ca
2+ influx during the second SOCC-
dependent phase that followed the initial release of Ca
2+
from intracellular stores. This store-operated Ca
2+ uptake
appeared to be essential for cell division since specific SOCC
antagonists completely blocked the PDGF- and golli-depend-
ent effects on OPC proliferation (Paez et al., 2009b).
Proliferation of OPCs is clearly important for normal
myelination as well as for remyelination in demyelinating
diseases. The above-mentioned study indicates that golli
overexpression increases the proliferation rate of OPCs as
assessed by several parameters including a decrease in the cell
cycle time. In contrast, golli-KO OPCs proliferated less
robustly and showed a significant increase in the length of
the cell cycle. Thus it is likely that golli promotes enhanced
proliferation of OPCs in the presence of mitogens. In this
regard, Filipovic and Zecevic (2005) reported that LPS
(lipopolysaccharide)-induced inflammation promoted OPC
proliferation through secretion of golli proteins from
activated microglia. In summary, golli MBPs can modulate
Ca
2+ uptake through VOCCs and SOCCs and this regulation
can directly affect early OPC functions such as process
remodelling, migration and proliferation.
Golli as an adaptor protein
By what mechanism could golli MBP modulate the activity of
Ca
2+ channels? It is possible that golli serves as an adaptor
protein in a complex that may directly or indirectly regulate
the activity of Ca
2+ channels (e.g. SOCCs and VOCCs)
(Figure 1). It is possible that this complex (or a similar one)
regulates cytoskeletal structures that lead to the observed
morphological changes in the OPC when golli (or CNP) are
overexpressed in OLs. This complex may also interact in some
way with the mitochondria and ER, which have been shown
by Simpson and Russell (1997) to be involved in regulating
the levels of Ca
2+ at Ca
2+-influx microdomains in OPC
processes and along the plasma-membrane surfaces of OPCs.
One possible role of golli is to serve as an adaptor protein as
part of a complex that might bridge the modulation of Ca
2+
influx through Ca
2+ channels, and the transduction of signals
from events at the membrane to the cytoskeleton. Essentially
all of the Ca
2+-mediated events in which golli plays a role
Figure 1 Hypothetical model of a golli-associated complex that may modulate the activity of Ca
2+ channels in OPCs
Golli is shown associated with the plasma membrane through a myristoylated moiety (purple) at its N-terminus, and in association
with the cytoskeleton, possibly through its MBP domain.
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tion, process extension and migration). Also, in immunopre-
cipitation/proteomic studies on membrane fractions, we have
consistently identified cytoskeletal proteins associated with
golli, particularly a-a n db-tubulin (C.W. Campagnoni,
unpublished work). This finding is significant since modu-
lation of ion channels and transporters by the actin and
tubulin components of the cytoskeleton is a common
phenomenon (Johnson and Byerly, 1993; Galli and DeFelice,
1994; Nakamura et al., 2000).
Golli has the appropriate physical properties to be an adaptor
protein in one of these regulatory complexes. To date, no
enzymatic activity has been associated with the golli proteins.
However, by virtue of their high hydrophilicity and net charge,
they fit the definition of intrinsically unstructured proteins.
Harauz et al. (2000) have shown that golli proteins form
extended structures in solution that would be ideal for binding
other molecules in a signalling assembly. This notion of golli
proteins serving as potential adaptor proteins in signalling
complexes is supported by other studies showing that they can
bind CaM in a Ca
2+-dependent fashion, and that they are also
able to bind phosphoinositides (Kaur et al., 2003). Additionally,
the N-terminal myristoylation of golli is essential for membrane
association and is critical for the ability of golli proteins to
regulate Ca
2+ uptake (Feng et al., 2006; Paez et al., 2007) and
migration (Paez et al., 2009a) in OPCs.
The classic MBPs
The classic MBPs bind to negatively charged lipids on the
cytosolic surface of the OL membrane, primarily through
electrostatic interactions (Boggs and Moscarello, 1982; Boggs
et al., 1982). They are present throughout compact internodal
myelin and are recognized to be involved in the adhesion of
the cytosolic surfaces of the multilayered myelin sheath,
where they have been localized by immunoelectron micro-
scopy and X-ray diffraction (Omlin et al., 1982; Readhead
et al., 1990; Kirschner and Blaurock, 1992).
However, proteins of the classic MBP family have been
found to bind to a number of molecules and targeted to
many subcellular locations (Hardy et al., 1996; Pedraza, 1997),
making it difficult to resolve the specific functions these
myelin proteins may play in cells. For example, the roles for
MBP have been suggested in the phosphoinositide signalling
pathway that affect axonal cytoskeletal organization (Wood
and Moscarello, 1997; Lintner and Dyer, 2000; Reyes and
Campagnoni, 2002), in the nucleus (Staugaitis et al., 1996), in
interactions with the cytoskeleton (Boggs et al., 2000, 2005,
2006; Boggs, 2006; Libich et al., 2003), and a regulatory
function on the expression of other myelin proteins (Hardy
et al., 1996; Carre et al., 2002).
There have, however, been consistent findings, suggesting
a possible role for classic MBPs in signal transduction
pathways and in cytoskeletal organization. Additionally, there
is an intriguing comparison of both golli and classic MBPs
with other proteins involved in signal transduction, such as
the MARCKS (myristoylated alanine-rich C-kinase substrate)
proteins (Arbuzova et al., 2002): classic and golli MBPs and
MARCKS are intrinsically unstructured, are phosphorylated by
both PKC (protein kinase C) and MAPK (mitogen-activated
protein kinase), bind acidic lipids strongly, and also bind CaM
and actin (Arbuzova et al., 2002).
Classic MBP interactions with cytoskeletal
proteins
Likegolliproteins, classicMBPs interact with the cytoskeleton in
OLs, in cytosolic inclusions in myelin, and even in compact
myelin, where classic MBP, actin and tubulin occur in the radial
component, a series of tight junctions that pass through many
layers of myelin (Pereyra et al., 1988; Gillespie et al., 1989;
Karthigasan et al., 1994). MBP in solution binds to F-actin in a
1:1 molar ratio and induces the formation of ordered bundles of
F-actin filaments (Barylko and Dobrowolski, 1984). It also binds
to G-actin in solution at an MBP/actin molar ratio of 1:2 and
causesitspolymerizationintofilamentsundernon-polymerizing
low ionic strength conditions (Dobrowolski et al., 1986; Roth et
al., 1993). MBP also binds Ca
2+-CaM (Grand and Perry, 1980;
Chan et al., 1990) and this interaction results in dissociation of
MBP from actin bundles (Barylko and Dobrowolski, 1984) and in
depolymerization of actin filaments bound to MBP in solution
(Dobrowolski et al., 1986). Binding to CaM has been shown to be
Ca
2+-dependent (Barylko and Dobrowolski, 1984, Dobrowolski
etal.,1986).AlthoughMBP caninteractwithactininsolution,it
is not known whether it can also interact with actin when MBP
is bound to the membrane surface. Along these lines, Boggs and
Rangaraj (2000) have shown that MBP can still interact with
actin filaments when it is bound to acidic lipid vesicles in vitro
and that CaM can still regulate binding of actin filaments under
these experimental conditions.
It is not yet known whether the interaction of classic MBP
with actin is a non-specific electrostatic interaction or if it
has a physiological role. However, the interaction of
membrane-bound MBP with actin suggests that MBP might
be able to bind actin to the cytosolic surface of the OL or
myelin plasma membrane. Co-localization studies by
immunohistochemistry indicate that MBP is closely assoc-
iated with microtubules and actin microfilaments in imma-
ture OLs (Wilson and Brophy, 1989). Recently, Boggs et al.
(2006) have shown that some MBPs are also co-localized with
actin at the edge of OL membrane sheets where they might
bind actin to the membrane and participate in membrane
sheet extension.
It has been repeatedly proposed that MBP may have a role in
the interactions of microtubules with membrane extensions,
raising the possibility that MBP may affect microtubule
functions essential for cell morphogenesis (Wilson and Brophy,
1989; Barry et al., 1996). In shiverer mice OLs, which lack MBP,
actin microfilaments are not co-localized with microtubular
structures as they are in the wild-type OLs (Dyer et al., 1995).
MBP is attached to the membrane through lipids and apparently
aligns with microtubules in sheet extensions (Lunn et al., 1997;
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33Song et al., 1999). Additionally, classic MBP has been suggested
to be involved in microtubule reorganization induced by anti-
Gal C antibody (Dyer and Benjamins, 1988). Consistent with a
role for classic MBP in microtubule regulation, it has been
shown that MBP has microtubule-stabilizing activity in vitro
(Pirollet et al., 1992), and that MBP can promote tubulin
assembly into microtubules and can bundle microtubules
in vitro (Hill et al., 2005). Previously, using RNAi techniques in
cells derived from control and MBP-deficient shiverer mice,
Galiano et al. (2006) have tested the microtubule-stabilizing
activity of MBP at late stages of OL differentiation. They showed
that MBP functions as a microtubule-stabilizing protein when
expressed and localized in cell processes.
Proteinase activity of classic MBPs
It was reported that purified MBP possesses endogenous
serine proteinase activity and can undergo autocatalytic
cleavage (D’Souza et al., 2005). Ser
151 was identified as the
active serine residue involved in autocatalysis (D’Souza et al.,
2005). Hoos et al. (2007, 2009) have shown that MBP binds
Ab (amyloid b-peptide) and inhibits Ab fibril formation. The
progressive accumulation of fibrillar Ab in senile plaques and
in the cerebral vasculature is the hallmark of Alzheimer’s
disease and related disorders. Recently, the same group has
reported that Ab peptides and assembled fibrillar Ab are
degraded by purified human brain MBP and recombinant
human MBP, both in vitro and in situ (Liao et al., 2009). MBP-
mediated Ab degradation is inhibited by serine proteinase
inhibitors, and cell lines expressing MBP degrade exogenous
Ab peptides in vitro (Liao et al., 2009). In addition, it has also
been proposed that MBP could counteract the surface
structure of Ab fibril-mediated cytotoxicity (Yoshiike et al.,
2007). In any case, future in vivo studies are warranted to
further examine the potential functions of classic MBPs in
the inhibition of Ab fibril assembly, Ab degradation and the
modulation of Ab-mediated cytotoxicity that may play a role
in the pathogenesis associated with amyloid deposition.
Classic MBP may serve in signalling complexes
Classic MBP has been classified as an intrinsically disordered
protein (Harauz et al., 2004). This unordered structure confers
on it the flexibility to interact with an array of negatively
charged surfaces and ligands, and to acquire whatever local
conformation is necessary to optimize binding to several
different targets. In addition to negatively charged lipids and
cytoskeletal proteins, the MBP classic isoforms are able to
interact with SH3-domain-containing proteins (Harauz and
Libich, 2009). Using SH3 domain microarrays, Polverini et al.
(2008) have found that the unmodified recombinant murine
18.5 kDa MBP isoform shows in vitro binding to the following
proteins containing SH3 domains: Yes1, PSD-95 (postsynaptic
density-95), cortactin, PexD, Abl, Fyn and c-Src. Recently,
Homchaudhuri et al. (2009) have shown that increasing the
negative surface charge of the membrane by increasing the
proportion of phosphatidylinositol reduces the amount of
Fyn-SH3 domain that binds to membrane-associated MBP.
These results suggest that changes in membrane-negative
surface charge due to protein or lipid modifications, which
could occur during cell signalling, can regulate the binding of
the Fyn-SH3 domain to MBP and thus could regulate the
activity of Fyn at the OL plasma membrane.
Theabilityofclassic MBPstobindcytoskeletalandsignalling
proteins containing SH3 domains to a lipid bilayer suggests
that,by functioningas a scaffoldingprotein in OLs or myelin, it
could act to organize these proteins into signalling complexes.
The interaction of MBP with the SH3 domains of proteins, in
addition to its already well-established interactions with
cytoskeletal proteins, points to a more defined role for MBP
in signal transduction. Although all of these studies have been
suggestive it is not yet known whether these findings underlie
a novel physiological function in cells.
SUMMARY
In conclusion, considerable progress has been made in
identifying alternative functions for some myelin protein
genes, and it is now clear that their products influence a
diverse array of cellular processes that are unrelated to their
well-known functions within the myelin membrane. In
particular, these proteins are able to interact with signalling
elements located at multiple levels in the pathways
regulating oligodendroglial function. For example, through
their influence on membrane receptors and ion channels PLP
and golli MBP regulate responses to external stimuli and
modulate the ensuing intracellular signals, while extensive
coupling to cytoskeletal structures places all of these
molecules in a prime position to regulate a wide variety of
cellular behaviours, including process extension, migration,
protein translation, proliferation and cell survival. Given this
multitude of influences, and a capacity to integrate within
signalling complexes, it appears that the products of myelin
protein genes contribute substantially to the physiological
development and function of cells at several stages in the
differentiation of the OL lineage. Finally, several of these
myelin proteins show prominent expression in developing
tissues located outside of the nervous system (O’Neill et al.,
1997; Marty et al., 2002; Feng et al., 2003, 2006; Skoff et al.,
2004a), suggesting that they play a wider role in the
regulation of processes contributing to development.
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